That's a valid point. But they also replicated their findings in two separate cohorts of 30 (see point #2) and 38 (see point #3) individuals who got the mRNA vaccine, making the total sample size close to 100. It's still low from the epidemiological viewpoint, but perhaps sufficient for biological studies.